Re: NFK meeting
|
2
|
Resverlogix Corp.
|
Feb 20, 2020 12:26PM
|
Best PR in all of 2019,... not counting the webcast
|
2
|
Resverlogix Corp.
|
Nov 29, 2019 05:31PM
|
Re: New MD&A posted
|
2
|
Resverlogix Corp.
|
Dec 17, 2019 08:09AM
|
Re: NFK meeting
|
2
|
Resverlogix Corp.
|
Feb 20, 2020 12:29PM
|
Re: Why didn't management do some phase 2's,....
|
2
|
Resverlogix Corp.
|
Jun 19, 2019 05:57PM
|
Re: Who's on twitter?
|
2
|
Resverlogix Corp.
|
Dec 06, 2019 09:43AM
|
Re: 1,300 warrants traded in all of December....
|
2
|
Resverlogix Corp.
|
Dec 31, 2018 02:37PM
|
Re: List of illlnesses our drugs could possibly treat...
|
2
|
Resverlogix Corp.
|
Feb 06, 2019 11:07AM
|
Re: Celebration meeting proposal!
|
2
|
Resverlogix Corp.
|
Sep 27, 2019 07:28PM
|
Re: 3 point MACE vs 5 point MACE
|
2
|
Resverlogix Corp.
|
Nov 02, 2018 02:19PM
|
Re: Adjudication
|
2
|
Resverlogix Corp.
|
Jan 29, 2019 05:57PM
|
Re: ACC 2019 Abstracts
|
2
|
Resverlogix Corp.
|
Mar 19, 2019 02:45PM
|
Anyone attending the AGM
|
2
|
Resverlogix Corp.
|
Oct 21, 2019 10:26AM
|
Re: MACE event rate
|
2
|
Resverlogix Corp.
|
Nov 05, 2018 10:56AM
|
Re: Warrant Exercise Incentive Program
|
2
|
Resverlogix Corp.
|
Nov 26, 2019 06:37AM
|
Re: ESC 2019 Symposium: Epigenetics: A new pathway to tackle residual risk?
|
2
|
Resverlogix Corp.
|
Jul 06, 2019 05:38AM
|
Does anyone here know personally the poster tundup,..?
|
2
|
Resverlogix Corp.
|
Apr 26, 2019 08:51AM
|
Re: rndbtl on IV - Sanofi's relationship with Rothschild
|
2
|
Resverlogix Corp.
|
Jan 14, 2019 04:21PM
|
Re: Probability of Phase 3 trial success
|
2
|
Resverlogix Corp.
|
Jun 22, 2019 10:09PM
|
Re: AHA Late Breaker!
|
2
|
Resverlogix Corp.
|
Sep 20, 2019 12:23PM
|